Andrew Armanino - Jul 27, 2023 Form 4 Insider Report for Better Therapeutics, Inc. (BTTX)

Role
Director
Signature
/s/ Mark Heinen, Attorney-in-Fact
Stock symbol
BTTX
Transactions as of
Jul 27, 2023
Transactions value $
$200,000
Form type
4
Date filed
7/31/2023, 07:58 AM
Previous filing
Jun 9, 2023
Next filing
Aug 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BTTX Common Stock Purchase $200K +274K +60.31% $0.73 728K Jul 27, 2023 By Armanino Trust F1, F2, F3
holding BTTX Common Stock 13.3K Jul 27, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 25, 2023, the Issuer entered into a Securities Purchase Agreement with certain investors (the "PIPE Investors") in a private placement offering, pursuant to which the PIPE Investors agreed to purchase shares of Issuer common stock for $0.7299 per share.
F2 As one of the PIPE Investors, the Reporting Person acquired 274,010 shares of Issuer common stock on July 27, 2023 for $0.7299 per share.
F3 These shares are owned directly by the Andrew J. Armanino III and Denise M. Armanino Family Trust (the "Armanino Trust"), and directly by the Reporting Person and his spouse, Denise M. Armanino, as trustees of the Armanino Trust.